Neptune Technologies & Bioressources-Ord (NEPT) EPS Estimated At $0.00, Hometrust Bancshares (HTBI) Sentiment Is 1.52

May 17, 2017 - By Winifred Garcia

Analysts expect Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) to report $0.00 EPS on May, 24. The stock increased 8.00% or $0.08 on May 16, reaching $1.08. About shares traded. Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) has risen 6.00% since April 17, 2017 and is uptrending. It has by 0.00% the S&P500.

HomeTrust Bancshares, Inc. is a bank holding firm of HomeTrust Bank . The company has market cap of $495.07 million. The Bank’s principal business consists of attracting deposits from the public and investing those funds, along with borrowed funds, in loans secured primarily by first and second mortgages on one- to four-family residences, including home equity loans, construction and land/lot loans, commercial real estate loans, construction and development loans, commercial and industrial loans, indirect automobile, and municipal leases. It has a 42.16 P/E ratio. Municipal leases are secured primarily by a ground lease for a firehouse or an equipment lease for fire trucks and firefighting equipment to fire departments located throughout North and South Carolina.

Investors sentiment is 1 in 2016 Q4. Its the same as in 2016Q3. It has no change, as 4 investors sold Neptune Technologies & Bioressources-Ord shares while 6 reduced holdings. only 4 funds opened positions while 6 raised stakes. 8.20 million shares or 2.58% more from 7.99 million shares in 2016Q3 were reported. Hillsdale invested 0.03% of its portfolio in Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT). Deutsche Comml Bank Ag has 17,400 shares for 0% of their portfolio. Geode Management Ltd Liability Com, a Massachusetts-based fund reported 54,010 shares. The California-based Lpl Limited Liability has invested 0% in Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT). Creative Planning holds 0% of its portfolio in Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) for 16,829 shares. Fiera reported 0% in Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT). Concannon Wealth Mgmt Lc holds 0% or 700 shares. Royal National Bank Of Canada has invested 0% in Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT). Credit Agricole S A stated it has 15 shares. Blair William & Il holds 0% or 10,800 shares in its portfolio. Financial Bank Of America Corp De owns 9,000 shares. 1832 Asset Mgmt L P reported 3,150 shares. Tower Capital Limited Company (Trc) has 0% invested in Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) for 2,000 shares. Morgan Stanley invested in 0% or 2,122 shares. Alpine Prns Vi invested in 0.07% or 148,101 shares.

Neptune Technologies & Bioressources Inc. is a solution well-known provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The company has market cap of $77.95 million. The Firm is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. It currently has negative earnings. The Company’s products include Krill-Based Nutraceutical Products, including Neptune Krill Oil , OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti.

The stock decreased 0.79% or $0.2 on May 16, reaching $25.15. About shares traded. Hometrust Bancshares Inc (NASDAQ:HTBI) has risen 6.00% since April 17, 2017 and is uptrending. It has by 0.00% the S&P500.

Analysts await Hometrust Bancshares Inc (NASDAQ:HTBI) to report earnings on August, 4. They expect $0.29 EPS, up 38.10% or $0.08 from last year’s $0.21 per share. HTBI’s profit will be $5.71 million for 21.68 P/E if the $0.29 EPS becomes a reality. After $0.27 actual EPS reported by Hometrust Bancshares Inc for the previous quarter, Wall Street now forecasts 7.41% EPS growth.

Ratings analysis reveals 50% of HomeTrust Bancshares’s analysts are positive. Out of 2 Wall Street analysts rating HomeTrust Bancshares, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. HTBI was included in 2 notes of analysts from August 3, 2015. The rating was downgraded by Keefe Bruyette & Woods on Friday, October 30 to “Market Perform”.

Since January 1, 0001, it had 0 buys, and 2 insider sales for $1.50 million activity.